文献速递乳房整形与再造美容整形

657例患者中乳房假体硅胶渗漏与包膜挛缩的关联

Silicone Leakage From Breast Implants and Its Association With Capsular Contracture in 657 Patients.
PubMed 文献 · Aesthet Surg J · 2025-01-01

这项多中心横断面研究纳入657例(1147侧乳房)硅胶假体乳房重建或隆乳后因任何指征行修复手术的患者,用组织病理学定量纤维包膜内硅胶、Baker分级诊断包膜挛缩。包膜挛缩与纤维包膜内硅胶量显著相关(P < .001),且独立于植入时间(P < .001);纤维包膜内硅胶从0.00 mL(0-32百分位)增至0.26 mL(60百分位)时,包膜挛缩超额风险快速增加12%(95% CI,5.0-18)。

要点

  • 包膜挛缩与纤维包膜内硅胶量显著相关(P < .001),独立于植入时间(P < .001)。
  • 纤维包膜内硅胶从0.00 mL(0-32百分位)增至0.26 mL(60百分位),包膜挛缩超额风险增加12%(95% CI,5.0-18)。
  • 在421例(654侧乳房)假体完整患者的敏感性分析中该关联得到确认,作者强调选用低硅胶渗漏率假体如高黏聚性假体以预防包膜挛缩。

核心结论

  • 即使少量硅胶渗漏也与包膜挛缩风险显著增加相关,作者强调使用低硅胶渗漏率的乳房假体(如高黏聚性假体)以预防包膜挛缩。

研究设计与样本

  • 多中心横断面研究,纳入657例(1147侧乳房)硅胶假体乳房重建或隆乳后因任何指征行修复手术的患者。
  • 用组织病理学分析定量纤维包膜内硅胶,用Baker分级诊断包膜挛缩,采用多变量逻辑回归评估硅胶渗漏量与包膜挛缩预测风险的关联。
  • 敏感性分析纳入421例(654侧乳房)假体完整的患者。

主要发现

  • 657例(1147侧乳房)中272例(346侧乳房)存在单侧或双侧包膜挛缩。
  • 包膜挛缩与纤维包膜内硅胶量显著相关(P < .001),且独立于植入时间(P < .001)。
  • 纤维包膜内硅胶从0.00 mL(0-32百分位)增至0.26 mL(60百分位)时,包膜挛缩超额风险快速增加12%(95% CI,5.0-18)。

临床怎么用

  • 作者认为应使用低硅胶渗漏率的乳房假体(如高黏聚性假体)以预防包膜挛缩。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Capsular contracture is a common complication following breast reconstruction and augmentation, but there is limited evidence for the association between silicone leaking from the implant and capsular contracture. OBJECTIVES: To determine the association between silicone leaking into the surrounding fibrous capsule and the risk of capsular contracture. METHODS: This multicenter cross-sectional study included patients undergoing revisional surgery for any indication following breast reconstruction or augmentation with silicone implants. Silicone in the fibrous capsule was quantified using histopathological analysis, and capsular contracture was diagnosed using the Baker classification. Multivariable logistic regression was used to assess the association between the amount of silicone leakage and the predicted risk of capsular contracture. The association was tested in a sensitivity analysis excluding potential confounders and misclassifications. RESULTS: Among 657 included patients (1147 breasts), 272 patients (346 breasts) had either unilateral or bilateral capsular contracture. Capsular contracture was significantly associated with the amount of silicone in the fibrous capsule (P < .001), independent from the time of implantation (P < .001). The excess risk of capsular contracture increased rapidly by 12% (95% CI, 5.0-18), going from 0.00 mL (0-32nd percentile) to 0.26 mL (60th percentile) of silicone in the fibrous capsule. The association was confirmed in the sensitivity analysis of 421 patients (654 breasts) with intact implants. CONCLUSIONS: Even small amounts of silicone leakage are associated with a significantly increased risk of capsular contracture. This highlights the importance of using breast implants with low silicone leakage rates, such as highly cohesive implants, to prevent capsular contracture.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Larsen A, Bak EEF, Weltz TK, et al. Silicone Leakage From Breast Implants and Its Association With Capsular Contracture in 657 Patients. Aesthet Surg J. 2025. PMID: 39888592. doi:10.1093/asj/sjaf012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。